BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27349612)

  • 1. [Nephrolithiasis of adult: From mechanisms to preventive medical treatment].
    Courbebaisse M; Prot-Bertoye C; Bertocchio JP; Baron S; Maruani G; Briand S; Daudon M; Houillier P
    Rev Med Interne; 2017 Jan; 38(1):44-52. PubMed ID: 27349612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephrolithiasis: From mechanisms to preventive medical treatment].
    Courbebaisse M; Prot-Bertoye C; Daudon M
    Nephrol Ther; 2020 Feb; 16(1):65-75. PubMed ID: 32122798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of nephrolithiasis in France].
    Daudon M
    Ann Urol (Paris); 2005 Dec; 39(6):209-31. PubMed ID: 16425740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of recurrent nephrolithiasis.
    Goldfarb DS; Coe FL
    Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
    Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive measures in stones due to infection, uric acid and cystine].
    Hess B; Ackermann D
    Ther Umsch; 1992 Jan; 49(1):44-8. PubMed ID: 1736401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.